KOHELOVA, E., J. MARIKOVA, J. KORABECNY, D. HULCOVA, T. KUCERA, D. JUN, J. CHLEBEK, J. JENCO, M. SAFRATOVA, M. HRABINOVA, A. RITOMSKA, Milan MALANÍK, R. PERINOVA, K. BREITEROVA, J. KUNES, L. NOVAKOVA, L. OPLETAL and L. CAHLIKOVA. Alkaloids of Zephyranthes citrina (Amaryllidaceae) and their implication to Alzheimer's disease: Isolation, structural elucidation and biological activity. Bioorganic Chemistry. SAN DIEGO: ACADEMIC PRESS INC ELSEVIER SCIENCE, 2021, vol. 107, No 104567, p. 1-11. ISSN 0045-2068. Available from: https://dx.doi.org/10.1016/j.bioorg.2020.104567.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Alkaloids of Zephyranthes citrina (Amaryllidaceae) and their implication to Alzheimer's disease: Isolation, structural elucidation and biological activity
Authors KOHELOVA, E., J. MARIKOVA, J. KORABECNY, D. HULCOVA, T. KUCERA, D. JUN, J. CHLEBEK, J. JENCO, M. SAFRATOVA, M. HRABINOVA, A. RITOMSKA, Milan MALANÍK (203 Czech Republic, belonging to the institution), R. PERINOVA, K. BREITEROVA, J. KUNES, L. NOVAKOVA, L. OPLETAL and L. CAHLIKOVA (guarantor).
Edition Bioorganic Chemistry, SAN DIEGO, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2021, 0045-2068.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.307
RIV identification code RIV/00216224:14160/21:00122468
Organization unit Faculty of Pharmacy
Doi http://dx.doi.org/10.1016/j.bioorg.2020.104567
UT WoS 000618103400009
Keywords in English Zephyranthes citrina; Amaryllidaceae; Alkaloids; Narcieliine; Alzheimer's disease; Docking studies
Tags rivok, ÚPL
Tags International impact, Reviewed
Changed by Changed by: JUDr. Sabina Krejčiříková, učo 383857. Changed: 23/3/2022 16:37.
Abstract
Twenty known Amaryllidaceae alkaloids of various structural types, and one undescribed alkaloid of narcikachnine-type, named narcieliine (3), have been isolated from fresh bulbs of Zephyranthes citrina. The chemical structures of the isolated alkaloids were elucidated by a combination of MS, HRMS, 1D and 2D NMR, and CD spectroscopic techniques, and by comparison with literature data. The absolute configuration of narcieliine (3) has also been determined. Compounds isolated in a sufficient quantity were evaluated for their in vitro acetylcholinesterase (AChE; E.C. 3.1.1.7), butyrylcholinesterase (BuChE; E.C. 3.1.1.8), and prolyl oligopeptidase (POP; E.C. 3.4.21.26) inhibition activities. Significant human AChE/BuChE (hAChE/hBuChE) inhibitory activity was demonstrated by the newly described alkaloid narcieliine (3), with IC50 values of 18.7 +/- 2.3 mu M and 1.34 +/- 0.31 mu M, respectively. This compound is also predicted to cross the blood-brain barrier (BBB) through passive diffusion. The in vitro data were further supported by in silico studies of 3 in the active site of hAChE/hBuChE.
PrintDisplayed: 26/7/2024 16:28